The Global Response to Mpox: Challenges, Progress, and Future Directions

The Global Response to Mpox: Challenges, Progress, and Future Directions The rapid spread of Mpox in Africa has raised significant concerns about the virus’s infectiousness and severity. The Democratic Republic of the Congo (DRC) has been particularly hard-hit, with a two-year-old child currently being treated for the disease. This outbreak has not been contained within […]

Moderna’s mRNA Mpox Vaccine Shows Superior Efficacy in Early Testing

Moderna’s mRNA Mpox Vaccine Shows Superior Efficacy in Early Testing In a groundbreaking study published in the journal Cell, Moderna’s experimental mRNA vaccine for monkeypox, also known as mpox, has demonstrated superior efficacy compared to currently licensed vaccines. This collaborative research, conducted by scientists from Moderna, the US Army Medical Research Institute of Infectious Diseases, […]

Bavarian Nordic, Mpox, Vaccine: Analyzing the Surge in Shares Amid Global Health Concerns

Bavarian Nordic, Mpox, Vaccine: Analyzing the Surge in Shares Amid Global Health Concerns The recent surge in share prices for Bavarian Nordic, a Danish vaccine manufacturer, has captured significant attention from investors and the global health community alike. This spike in stock value is primarily driven by the increasing demand for their mpox vaccine, Jynneos, […]

Mpox: Vaccine Group Gavi Allocates $500 Million for Shots Amid Health Emergency

Mpox: Vaccine Group Gavi Allocates $500 Million for Shots Amid Health Emergency The recent mpox outbreak in Africa has prompted swift action from global health organizations, with the vaccine group Gavi leading the charge. Gavi has announced that it has up to $500 million available to spend on procuring and distributing vaccines to affected countries. […]

Bavarian Nordic Secures $157M Contract to Replenish US Supplies of Smallpox/Mpox Vaccine Jynneos

Bavarian Nordic Secures $157M Contract to Replenish US Supplies of Smallpox/Mpox Vaccine Jynneos Bavarian Nordic, a Danish biotechnology company, has recently secured a substantial contract worth $156.8 million from the United States government to replenish the nation’s stockpile of the smallpox and mpox vaccine, Jynneos. This deal marks a significant milestone for Bavarian Nordic as […]